Health Direct- NHS news, advice and information

Recent Posts

Tag Cloud

Site search

Site menu:

Archives

HON- Accreditation

The Health Direct blog adheres to the eight principles of the Health On the Net’s HON Code of Conduct (HONcode) for medical and health websites.

This website is certified by Health On the Net Foundation.

Categories

Links:

HEALTH TWITTER

Recent Comments

Statins help prevent cancer in transplant patients

Statins may reduce the risk of cancer in heart transplant patients, as scientists find a new use for the drugs.Statins help prevent cancer in transplant patientsTransplant patients can safely be put on statins because they may reduce the risk of cancer, a common side effect of the operation, research has found.

A study of transplant recipients in Switzerland has found that those on statins were less likely to develop cancer and less likely to die than those who were not taking the drug.

The effect did not depend on the patient’s cholesterol levels suggesting the drug may have other effects that have not been discovered until now.

The findings were presented at the Heart Failure Congress, a meeting of the European Society of Cardiology, in Belgrade, Serbia.

It comes after researchers said everyone over the age of 50 should be prescribed statins because they reduced the risk of a heart attack or stroke even in those at a relatively low risk.

Cancer is the leading cause of death after heart transplantation in those who survive the initial operation and recovery.

The drugs to surpress the immune system and prevent donor organs from being rejected are known to increase the risk of cancer.

The study included all 255 patients who underwent heart transplantation at the University Hospital Zurich in Switzerland between 1985 and 2007 and were alive after the first year.

Four in ten were later diagnosed with cancer, however those on a statin were 65 per cent less likely to develop cancer.

Eight years after transplantation more than a third of people who were not taking statins had developed cancer compared with 13 per cent of those taking the drugs.

The benefit persisted in the long term as 42 per cent of those not on statins had cancer 12 years after their transplant compared with 22 per cent of those taking them.

Guidelines from the International Society for Heart & Lung Transplantation recommend giving a statin to patients after heart transplantation to reduce narrowing of the arteries.

«